Literature DB >> 7581269

Pathogenesis of Rhodococcus equi infection in mice: roles of virulence plasmids and granulomagenic activity of bacteria.

S Takai1, H Madarame, C Matsumoto, M Inoue, Y Sasaki, Y Hasegawa, S Tsubaki, A Nakane.   

Abstract

Virulence of Rhocococcus equi ATCC 33701 and its plasmid-cured derivative ATCC 33701P- was compared in BALB/c and C3H/HeJ mice in terms of bacterial growth kinetics and histological changes in the liver, spleen and lungs, and humoral immune responses. Injection with a sublethal dose of 10(6) ATCC 33701 in mice resulted in microabscess formation after rapid multiplication in the liver and spleen by day 4, and then the bacteria were gradually eliminated with the formation of granuloma and the production of specific antibodies against 15- to 17-kDa antigens of the virulent bacteria. By contrast, ATCC 33701P- was avirulent as shown by early elimination of viable bacteria and no evidence of net multiplication in the organs. Histopathological changes consisted of only slight, transient infiltration of neutrophils and macrophages in the liver. Although live ATCC 33701P- did not evoke any humoral or histological responses in the mice, a large inoculum (10(8)) of killed ATCC 33701 and ATCC 33701P- resulted in the formation of granuloma in the liver and accelerated extramedullary hemopoiesis in the spleen. These results suggest that the pathogenesis of R. equi infection involves at least two important virulence determinants, both of which play critical roles in the disease: one is the virulence plasmid, which is required for R. equi to resist and grow within host cells; and the other is the granulomagenic activity that is related to the lipids and nature of the cell wall of the species, which induces the characteristic pathological changes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581269     DOI: 10.1111/j.1574-695X.1995.tb00115.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  11 in total

1.  Phenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesis.

Authors:  Joseph Ashour; Mary K Hondalus
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

2.  Serologic responses to Rhodococcus equi in individuals with and without human immunodeficiency virus infection.

Authors:  V Vullo; C M Mastroianni; M Lichtner; F Mengoni; E Chiappini; C D'Agostino; S Delia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

3.  Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi.

Authors:  S Giguère; J F Prescott
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi.

Authors:  H Kasuga-Aoki; S Takai; Y Sasaki; S Tsubaki; H Madarame; A Nakane
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

5.  Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.

Authors:  S Giguère; M K Hondalus; J A Yager; P Darrah; D M Mosser; J F Prescott
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  An Autobioluminescent Method for Evaluating In Vitro and In Vivo Growth of Rhodococcus equi.

Authors:  Yasunori Suzuki; Naho Sakaizawa; Shinji Takai; Hiroaki Kubota; Noeru Hasegawa; Yukako Sasaki; Tsutomu Kakuda
Journal:  Microbiol Spectr       Date:  2022-05-31

7.  Identification of intermediately virulent Rhodococcus equi isolates from pigs.

Authors:  S Takai; N Fukunaga; S Ochiai; Y Imai; Y Sasaki; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Necrotic death of Rhodococcus equi-infected macrophages is regulated by virulence-associated plasmids.

Authors:  Anja Lührmann; Norman Mauder; Tobias Sydor; Eugenia Fernandez-Mora; Jan Schulze-Luehrmann; Shinji Takai; Albert Haas
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 9.  Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection.

Authors:  R Linder
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

10.  An Adenoviral Vector Based Vaccine for Rhodococcus equi.

Authors:  Carla Giles; Olasumbo Ndi; Mary D Barton; Thiru Vanniasinkam
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.